Mrs. Beverly Wolf Luedke, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 701 Murray Ave, Rockdale, TX 76567 Phone: 512-446-9990 Fax: 512-446-9991 |
Laurel Herzog, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1700 Brazos Ave, Rockdale, TX 76567 Phone: 512-430-6466 |
Mrs. Nia Malika Jackson-lewis, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 701 Murray Ave, Rockdale, TX 76567 Phone: 512-446-9990 Fax: 512-446-9991 |
Mr. Christopher Jones, D.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1701 Pecos Ave, Rockdale, TX 76567 Phone: 512-430-6466 |
News Archive
Botox, or botulinum toxin type A, which is best-known for smoothing away facial wrinkles is to be tested as an asthma treatment at Melbourne's Monash University. A recent survey by the university found that about half of severe asthmatics suffer problems with their voice box as well as their lungs. The problems were similar to vocal cord dysphonia – or loss of voice through overuse – a condition which Botox is frequently used to fix.
Today's headlines include reports about the health law's implementation and status checks on how the measure's online insurance marketplaces are taking shape.
Oncologists from NewYork-Presbyterian, Columbia University Medical Center and Weill Cornell Medicine will discuss their latest research findings at the American Society for Clinical Oncology annual meeting, June 3-7 in Chicago.
A clinical trial evaluating the benefit of adding the drug sorafenib to the combination of carboplatin/paclitaxel chemotherapy for lung cancer patients has been stopped based on results from an interim analysis, after an independent data monitoring committee concluded that the study would not meet its primary endpoint of improved overall survival.
Duke University physicists have developed a way to produce sharp fluid jets with enough precision that they can inject material into a single, living cell. The technique promises a way to deliver drugs to cells one at a time, which is likely to be very valuable for research involving stem cells and other cellular-level studies. The research appears in the current issue of the APS journal Physical Review Letters.
› Verified 8 days ago